Anders Sundin

Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial

Hahn, Amanda; Irenaeus, Sandra; Sandin, Linda C.; Nordström, Clara et al.

Part of Clinical Cancer Research, p. 3157-3168, 2026

• DOI for Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)

Deroose, Christophe M.; Leupe, Hannes; Hicks, Rodney J.; Virgolini, Irene et al.

Part of The Lancet Oncology, 2026

• DOI for Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)

¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

Vyakaranam, Achyut Ram; Norlén, Olov; Akural, Alina; Crona, Joakim et al.

Part of Journal of neuroendocrinology, 2026

• DOI for ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.
• Download full text (pdf) of ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer

Fridsten, Susanne; Hellman, Kristina; Sundin, Anders; Nedar, Lennart

Part of European Journal of Radiology, 2026

• DOI for Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer
• Download full text (pdf) of Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer

Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs

Klimàcek, Branislav; Åkerström, Tobias; Annebäck, Matilda; Hellman, Per et al.

Part of Endocrine-Related Cancer, 2025

• DOI for Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs
• Download full text (pdf) of Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs

Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial

Hahn, Amanda; Irenaeus, Sandra; Sandin, Linda C.; Nordström, Clara et al.

Part of Clinical Cancer Research, p. 3157-3168, 2026

• DOI for Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial

¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

Vyakaranam, Achyut Ram; Norlén, Olov; Akural, Alina; Crona, Joakim et al.

Part of Journal of neuroendocrinology, 2026

• DOI for ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.
• Download full text (pdf) of ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer

Fridsten, Susanne; Hellman, Kristina; Sundin, Anders; Nedar, Lennart

Part of European Journal of Radiology, 2026

• DOI for Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer
• Download full text (pdf) of Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer

Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs

Klimàcek, Branislav; Åkerström, Tobias; Annebäck, Matilda; Hellman, Per et al.

Part of Endocrine-Related Cancer, 2025

• DOI for Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs
• Download full text (pdf) of Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Papantoniou, Dimitrios; Fröss-Baron, Katarzyna; Garske Roman, Ulrike; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2025

• DOI for Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
• Download full text (pdf) of Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force

Prasad, Vikas; Koumarianou, Anna; Denecke, Timm; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2025

• DOI for Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force

Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours

Wedin, Maria; Tiensuu Janson, Eva; Wallin, Göran; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2025

• DOI for Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours
• Download full text (pdf) of Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours

Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden

O. Ladjevardi, Cecilia; Naeser, Ylva; Dyrke, Ulf; Papantoniou, Dimitrios et al.

Part of The Lancet Oncology, p. 1501-1510, 2025

• DOI for Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden

The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Mollazadegan, Kazhan; Botling, Johan; Skogseid, Britt; Eriksson, Barbro et al.

Part of Journal of neuroendocrinology, 2025

• DOI for The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
• Download full text (pdf) of The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[¹⁸F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism

Gillett, Daniel; Senanayake, Russell; MacFarlane, James; Bashari, Waiel et al.

Part of Journal of Nuclear Medicine, p. 434-440, 2025

• DOI for A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[¹⁸F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism

The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Holmstrand, Hanna; Lindskog, Magnus; Sundin, Anders; Hansen, Tomas

Part of Cancer Imaging, 2025

• DOI for The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer
• Download full text (pdf) of The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Radiation dosimetry of para-chloro-2-[¹⁸F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging

Silins, Isabella; Moreno, Adrian; Wall, Anders; Aigbirhio, Franklin et al.

Part of EJNMMI Research, 2024

• DOI for Radiation dosimetry of para-chloro-2-[¹⁸F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging
• Download full text (pdf) of Radiation dosimetry of para-chloro-2-[¹⁸F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging

Use and perceived utility of [¹⁸ F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022

Ambrosini, Valentina; Caplin, Martyn; Castaño, Justo P; Christ, Emanuel et al.

Part of Journal of neuroendocrinology, 2024

• DOI for Use and perceived utility of [¹⁸ F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022

Changes in Tumor-to-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT

Weber, Manuel; Pettersson, Olof; Seifert, Robert; Schaarschmidt, Benedikt Michael et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 841-851, 2024

• DOI for Changes in Tumor-to-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
• Download full text (pdf) of Changes in Tumor-to-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT

Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

Wedin, Maria; Tiensuu Janson, Eva; Wallin, Göran; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2024

• DOI for Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
• Download full text (pdf) of Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Backman, Samuel; Botling, Johan; Nord, Helena; Ghosal, Suman et al.

Part of Journal of Pathology, p. 357-370, 2024

• DOI for The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
• Download full text (pdf) of The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Improved Localization of Insulinomas Using ⁶⁸Ga-NODAGA-Exendin-4 PET/CT

Boss, Marti; Eriksson, Olof; Mikkola, Kirsi; Eek, Annemarie et al.

Part of Journal of Nuclear Medicine, p. 1959-1964, 2024

• DOI for Improved Localization of Insulinomas Using ⁶⁸Ga-NODAGA-Exendin-4 PET/CT
• Download full text (pdf) of Improved Localization of Insulinomas Using ⁶⁸Ga-NODAGA-Exendin-4 PET/CT

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Falkman, Lovisa; Sundin, Anders; Skogseid, Britt; Botling, Johan et al.

Part of Upsala Journal of Medical Sciences, 2024

• DOI for Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
• Download full text (pdf) of Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes

Vyakaranam, Achyut Ram; Mahamed, Maryama M.; Hellman, Per; Eriksson, Olof et al.

Part of Diabetologia, p. 199-208, 2024

• DOI for Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes
• Download full text (pdf) of Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes

Många binjureincidentalom får ingen adekvat utredning: Reviderade riktlinjer kan förenkla handläggningen

Muth, Andreas; Sundin, Anders; Zedenius, Jan

Part of Läkartidningen, 2023

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Panzuto, Francesco; Ramage, John; Pritchard, D Mark; van Velthuysen, Marie-Louise F et al.

Part of Journal of neuroendocrinology, 2023

• DOI for European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3
• Download full text (pdf) of European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Adrenal cysts: an emerging condition.

Calissendorff, Jan; Juhlin, C. Christofer; Sundin, Anders; Bancos, Irina et al.

Part of Nature Reviews Endocrinology, p. 398-406, 2023

• DOI for Adrenal cysts: an emerging condition.

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Dam, Gitte; Grønbæk, Henning; Sundlöv, Anna; Botling, Johan et al.

Part of Acta Oncologica, p. 431-437, 2023

• DOI for Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Improved health‐related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours

Edfeldt, Katarina; Hellman, Per; Granberg, Dan; Lagergren, Pernilla et al.

Part of Journal of neuroendocrinology, 2023

• DOI for Improved health‐related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours
• Download full text (pdf) of Improved health‐related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours

Rare benign adrenal lesions

Dogra, Prerna; Sundin, Anders; Juhlin, C. Christofer; Calissendorff, Jan et al.

Part of European Journal of Endocrinology, p. 407-420, 2023

• DOI for Rare benign adrenal lesions

Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression

Jahn, Ulrika; Garske-Román, Ulrike; Sandström, Mattias; Lubberink, Mark et al.

Part of EJNMMI Research, p. 45, 2023

• DOI for Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression
• Download full text (pdf) of Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression

First-in-human evaluation of [¹⁸F]CETO: a novel tracer for adrenocortical tumours

Silins, Isabella; Sundin, Anders; Lubberink, Mark; O'Sullivan, Lleah et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 398-409, 2023

• DOI for First-in-human evaluation of [¹⁸F]CETO: a novel tracer for adrenocortical tumours
• Download full text (pdf) of First-in-human evaluation of [¹⁸F]CETO: a novel tracer for adrenocortical tumours

Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)

Naeser, Ylva; Helgadottir, Hildur; Hansson, Johan; Ingvar, Christian et al.

Part of Cancers, 2022

• DOI for Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
• Download full text (pdf) of Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Mollazadegan, Kazhan; Skogseid, Britt; Botling, Johan; Åkerström, Tobias et al.

Part of Endocrine Connections, 2022

• DOI for Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
• Download full text (pdf) of Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

Hicks, Rodney J.; Dromain, Clarisse; de Herder, Wouter W.; Costa, Frederico P. et al.

Part of Journal of neuroendocrinology, 2022

• DOI for ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours
• Download full text (pdf) of ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours

Dromain, Clarisse; Vullierme, Marie-Pierre; Hicks, Rodney J.; Prasad, Vikas et al.

Part of Journal of neuroendocrinology, 2022

• DOI for ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
• Download full text (pdf) of ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours

Primary hyperparathyroidism, a machine learning approach to identify multiglandular disease in patients with a single adenoma found at preoperative Sestamibi-SPECT/CT

Sandqvist, Patricia; Sundin, Anders; Nilsson, Inga-Lena; Gryback, Per et al.

Part of European Journal of Endocrinology, p. 257-263, 2022

• DOI for Primary hyperparathyroidism, a machine learning approach to identify multiglandular disease in patients with a single adenoma found at preoperative Sestamibi-SPECT/CT

Commentary on Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant masses

Sundin, Anders

Part of European Journal of Endocrinology, 2022

• DOI for Commentary on Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant masses
• Download full text (pdf) of Commentary on Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant masses

Graft-versus-Mastocytosis Effect After Donor Lymphocyte Infusion: Proof of Principle.

Hägglund, Hans; Selim Yavuz, Akif; Dreimane, Arta; Malm, Claes et al.

Part of European Journal of Haematology, p. 290-293, 2021

• DOI for Graft-versus-Mastocytosis Effect After Donor Lymphocyte Infusion: Proof of Principle.
• Download full text (pdf) of Graft-versus-Mastocytosis Effect After Donor Lymphocyte Infusion: Proof of Principle.

The preoperative localisation of small parathyroid adenomas improves when adding Tc-99m-Sestamibi SPECT to multiphase contrast-enhanced CT

Sandqvist, Patricia; Farnebo, Jacob; Nilsson, Inga-Lena; Grybäck, Per et al.

Part of Insights into Imaging, 2021

• DOI for The preoperative localisation of small parathyroid adenomas improves when adding Tc-99m-Sestamibi SPECT to multiphase contrast-enhanced CT
• Download full text (pdf) of The preoperative localisation of small parathyroid adenomas improves when adding Tc-99m-Sestamibi SPECT to multiphase contrast-enhanced CT

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Jahn, Ulrika; Ilan, Ezgi; Velikyan, Irina; Fröss-Baron, Katarzyna et al.

Part of EJNMMI Research, 2021

• DOI for Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT
• Download full text (pdf) of Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.

Pettersson, Olof; Fröss-Baron, Katarzyna; Crona, Joakim; Sundin, Anders

Part of Endocrine Connections, p. 422-431, 2021

• DOI for Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.
• Download full text (pdf) of Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.

Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Lubberink, Mark et al.

Part of Cancers, 2021

• DOI for Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms
• Download full text (pdf) of Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Prospective data-driven respiratory gating of [Ga-68]Ga-DOTATOC PET/CT

Sigfridsson, Jonathan; Lindström, Elin; Iyer, Victor; Holstensson, Maria et al.

Part of EJNMMI Research, 2021

• DOI for Prospective data-driven respiratory gating of [Ga-68]Ga-DOTATOC PET/CT
• Download full text (pdf) of Prospective data-driven respiratory gating of [Ga-68]Ga-DOTATOC PET/CT

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Tiensuu Janson, Eva; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte et al.

Part of Acta Oncologica, p. 931-941, 2021

• DOI for Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
• Download full text (pdf) of Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Knee function 30 years after ACL reconstruction: a case series of 60 patients.

Söderman, Tomas; Werner, Suzanne; Wretling, Marie-Louise; Hänni, Mari et al.

Part of Acta Orthopaedica, p. 716-721, 2021

• DOI for Knee function 30 years after ACL reconstruction: a case series of 60 patients.

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Baudin, E.; Caplin, M.; Garcia-Carbonero, R.; Fazio, N. et al.

Part of Annals of Oncology, p. 439-451, 2021

• DOI for Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Part of Neuroendocrinology, p. 330-343, 2021

• DOI for 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
• Download full text (pdf) of 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging

Jawlakh, Hiba; Velikyan, Irina; Welin, Staffan; Sundin, Anders

Part of Journal of neuroendocrinology, 2021

• DOI for Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging
• Download full text (pdf) of Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging

Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability

Dromain, Clarisse; Sundin, Anders; Najran, Pavan; Vidal Trueba, Hector et al.

Part of Neuroendocrinology, p. 831-839, 2021

• DOI for Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability

Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging

Silins, Isabella; Sundin, Anders; Nordeman, Patrik; Jahan, Mahabuba et al.

Part of International Journal of Medical Sciences, p. 2187-2196, 2021

• DOI for Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging
• Download full text (pdf) of Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging

¹¹C-metomidate PET/CT detected multiple ectopic adrenal rest tumors in a woman with congenital adrenal hyperplasia

Burman, Pia; Falhammar, Henrik; Waldenström, Erik; Sundin, Anders et al.

Part of Journal of Clinical Endocrinology and Metabolism, 2021

• DOI for ¹¹C-metomidate PET/CT detected multiple ectopic adrenal rest tumors in a woman with congenital adrenal hyperplasia

Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Irenaeus, Sandra; Hellström, Vivan; Wenthe, Jessica; Krause, Johan et al.

Part of Cancer Gene Therapy, p. 1188-1197, 2021

• DOI for Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Inter-observer agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer.

Pálsdóttir, K; Fridsten, S; Blomqvist, L; Alagic, Z et al.

Part of Ultrasound in Obstetrics and Gynecology, p. 773-779, 2021

• DOI for Inter-observer agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer.

A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses

Sundin, Anders; Hindie, Elif; Avram, Anca M.; Tabarin, Antoine et al.

Part of Journal of Nuclear Medicine, 2021

• DOI for A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses

TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma

Naeser, Ylva; Helgadottir, Hildur; Brandberg, Yvonne; Hansson, Johan et al.

Part of BMC Cancer, 2020

• DOI for TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
• Download full text (pdf) of TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma

Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Pettersson, Olof; Fröss-Baron, Katarzyna; Crona, Joakim; Sundin, Anders

Part of Frontiers in Oncology, 2020

• DOI for Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients
• Download full text (pdf) of Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Part of Neuroendocrinology, p. 662-670, 2020

• DOI for ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE.

Ilan, Ezgi; Velikyan, Irina; Sandström, Mattias; Sundin, Anders et al.

Part of Journal of Nuclear Medicine, p. 217-221, 2020

• DOI for Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE.

Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Sandström, Mattias; Freedman, Nanette; Fröss-Baron, Katarzyna; Khan, Tanweera et al.

Part of EJNMMI Physics, 2020

• DOI for Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
• Download full text (pdf) of Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Evaluation of block-sequential regularized expectation maximization reconstruction of ⁶⁸Ga-DOTATOC, ¹⁸F-fluoride, and ¹¹C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner

Lindström, Elin; Lindsjö, Lars; Sundin, Anders; Sörensen, Jens et al.

Part of EJNMMI Physics, 2020

• DOI for Evaluation of block-sequential regularized expectation maximization reconstruction of ⁶⁸Ga-DOTATOC, ¹⁸F-fluoride, and ¹¹C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner
• Download full text (pdf) of Evaluation of block-sequential regularized expectation maximization reconstruction of ⁶⁸Ga-DOTATOC, ¹⁸F-fluoride, and ¹¹C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner

Higher frequency of osteoarthritis in patients with ACL graft rupture than in those with intact ACL grafts 30 years after reconstruction

Söderman, Tomas; Wretling, Marie-Louise; Hänni, Mari; Mikkelsen, Christina et al.

Part of Knee Surgery, Sports Traumatology, Arthroscopy, p. 2139-2146, 2020

• DOI for Higher frequency of osteoarthritis in patients with ACL graft rupture than in those with intact ACL grafts 30 years after reconstruction
• Download full text (pdf) of Higher frequency of osteoarthritis in patients with ACL graft rupture than in those with intact ACL grafts 30 years after reconstruction

In vivo instability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Lubberink, Mark; Wilking, Helena; Öst, Amalia; Ilan, Ezgi et al.

Part of Journal of Nuclear Medicine, p. 1337-1340, 2020

• DOI for In vivo instability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Pavel, M.; Öberg, Kjell; Falconi, M.; Krenning, E. P. et al.

Part of Annals of Oncology, p. 844-860, 2020

• DOI for Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Dam, Gitte; Gronbaek, Henning; Sorbye, Halfdan; Evensen, Espen Thiis et al.

Part of Neuroendocrinology, p. 217-224, 2020

• DOI for Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Schiza, Aglaia; Irenaeus, Sandra; Ortiz-Nieto, Francisco; Loskog, Angelica S. et al.

Part of Scientific Reports, 2019

• DOI for Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients
• Download full text (pdf) of Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Regularized reconstruction of digital time-of-flight Ga-68-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients

Lindström, Elin; Velikyan, Irina; Regula, Naresh Kumar; Alhuseinalkhudhur, Ali et al.

Part of Theranostics, p. 3476-3484, 2019

• DOI for Regularized reconstruction of digital time-of-flight Ga-68-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients
• Download full text (pdf) of Regularized reconstruction of digital time-of-flight Ga-68-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

Vyakaranam, Achyut Ram; Crona, Joakim; Norlén, Olov; Granberg, Dan et al.

Part of Cancers, 2019

• DOI for Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.
• Download full text (pdf) of Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

C-11-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma

Vyakaranam, Achyut Ram; Crona, Joakim; Norlén, Olov; Hellman, Per et al.

Part of Cancers, 2019

• DOI for C-11-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma
• Download full text (pdf) of C-11-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma

Multiphase Iodine Contrast-Enhanced SPECT/CT Outperforms Nonenhanced SPECT/CT for Preoperative Localization of Small Parathyroid Adenomas

Sandqvist, Patricia; Nilsson, Inga-Lena; Grybäck, Per; Sanchez-Crespo, Alejandro et al.

Part of Clinical Nuclear Medicine, p. 929-935, 2019

• DOI for Multiphase Iodine Contrast-Enhanced SPECT/CT Outperforms Nonenhanced SPECT/CT for Preoperative Localization of Small Parathyroid Adenomas

Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours: the GREPONET-2 study

Lamarca, Angela; Ronot, Maxime; Moalla, Salma; Crona, Joakim et al.

Part of Clinical Cancer Research, p. 6692-6699, 2019

• DOI for Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours: the GREPONET-2 study

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET): The GREPONET Study

Lamarca, Angela; Crona, Joakim; Ronot, Maxime; Opalinska, Marta et al.

Part of The Oncologist, 2019

• DOI for Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET): The GREPONET Study

Response to Prof. Ingo Brink and Prof. Aubalewska-Dydejczyk regarding Their "Letter to the Editor".

Sundin, Anders; Fanti, Stefano; Giammarile, Francesco; de Herder, Wouter W

Part of Neuroendocrinology, p. 366-366, 2019

• DOI for Response to Prof. Ingo Brink and Prof. Aubalewska-Dydejczyk regarding Their "Letter to the Editor".

Unmet Needs in Functional and Nonfunctional pancreatic neuroendocrine neoplasms

Jensen, Robert T.; Bodei, Lisa; Capdevila, J.; Couvelard, Anne et al.

Part of Neuroendocrinology, p. 26-36, 2019

• DOI for Unmet Needs in Functional and Nonfunctional pancreatic neuroendocrine neoplasms

Colorectal Neuroendocrine Neoplasms - areas of unmet need

Ramage, John K; Valle, Juan; Nieveen van Dijkum, Els J M; Sundin, Anders et al.

Part of Neuroendocrinology, p. 45-53, 2019

• DOI for Colorectal Neuroendocrine Neoplasms - areas of unmet need

Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations

Lindström, Elin; Sundin, Anders; Trampal, Carlos; Lindsjö, Lars et al.

Part of Journal of Nuclear Medicine, p. 1152-1158, 2018

• DOI for Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations

Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The Greponet Study

Lamarca, A.; Crona, Joakim; Ronot, M.; Opalinska, M. et al.

Part of Neuroendocrinology, p. 178-178, 2018

• DOI for Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The Greponet Study

Kidney dosimetry during (177)Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance

Sandström, Mattias; Garske, Ulrike; Johansson, Silvia; Granberg, Dan et al.

Part of Acta Oncologica, p. 516-521, 2018

• DOI for Kidney dosimetry during (177)Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance

In-vivo stability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Wilking, H.; Ilan, Ezgi; Sandström, Mattias; Andersson, C. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for In-vivo stability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Image contrast of ¹⁷⁷Lu-filled spheres as measured with a GE Discovery 670 CZT SPECT/CT system

Sandström, Mattias; Sundin, Anders; Lubberink, Mark; Ljungberg, M.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Image contrast of ¹⁷⁷Lu-filled spheres as measured with a GE Discovery 670 CZT SPECT/CT system

Regularized Reconstruction of Ga-68-PSMA Whole-Body Examinations Acquired on a Digital Time-of-Flight PET/CT Scanner

Lindström, Elin; Regula, Naresh Kumar; Sundin, Anders; Sörensen, Jens et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Comparison of Ga-68-DOTATATE and Lu-177-DOTATATE kinetics in neuroendocrine tumors

Ilan, Ezgi; Lubberink, Mark; Sandström, Mattias; Jahn, Ulrika et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy; Gender Differences in Small Intestinal and Pancreatic Neuroendocrine Tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Sandström, Mattias; Fröss-Baron, Katarzyna; Khan, Tanweera Shaheena; Granberg, Dan et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Novel Functional Imaging of Neuroendocrine Tumors

Sundin, Anders

Part of Endocrinology and metabolism clinics of North America (Print), p. 505-523, 2018

• DOI for Novel Functional Imaging of Neuroendocrine Tumors

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Garske, Ulrike; Sandström, Mattias; Fröss-Baron, Katarzyna; Lundin, Lars et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 970-988, 2018

• DOI for Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
• Download full text (pdf) of Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Preoperative Ga-68-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions

Norlén, Olov; Montan, Harald; Hellman, Per; Stålberg, Peter et al.

Part of World Journal of Surgery, p. 498-505, 2018

• DOI for Preoperative Ga-68-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions

Anatomic distribution of hematoma following pelvic fracture

Uludag, Narin; Tötterman, Anna; Beckman, Mats O; Sundin, Anders

Part of British Journal of Radiology, 2018

• DOI for Anatomic distribution of hematoma following pelvic fracture

A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors

Dam, G.; Grønbæk, H.; Sørbye, H.; Thiis-Evensen, E. et al.

Part of Neuroendocrinology, p. 152-152, 2018

• DOI for A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Irenaeus, Sandra; Schiza, Aglaia; Mangsbo, Sara M.; Wenthe, Jessica et al.

Part of Oncotarget, p. 78573-78587, 2017

• DOI for Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
• Download full text (pdf) of Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA

Bozkurt, Murat Fani; Virgolini, Irene; Balogova, Sona; Beheshti, Mohsen et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1588-1601, 2017

• DOI for Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA

Parametric Net Influx Rate Images of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast

Ilan, Ezgi; Sandström, Mattias; Velikyan, Irina; Sundin, Anders et al.

Part of Journal of Nuclear Medicine, p. 744-749, 2017

• DOI for Parametric Net Influx Rate Images of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast

Neuroendocrine tumors with syndromic vasoactive intestinal polypeptide hypersecretion: a retrospective study

Antonodimitrakis, Pantelis Clewemar; Olofsson, Helena; Grimelius, Lars; Sundin, Anders et al.

Part of International Journal of Endocrine Oncology, p. 9-22, 2017

• DOI for Neuroendocrine tumors with syndromic vasoactive intestinal polypeptide hypersecretion: a retrospective study

Low tracer availability of Ga-68-DOTATOC and Ga-68-DOTATATE in blood for patients with high SSTR density leads to non-linear correlation between SUV and K-i

Ilan, Ezgi; Sundin, Anders; Velikyan, Irina; Sandström, Mattias et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Optimisation of penalized likelihood estimation reconstruction on a digital time-of-flight PET-CT scanner for four different PET tracers

Lindström, Elin; Sundin, Anders; Trampal, Carlos; Lindsjö, Lars et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

Gender-related differences in absorbed dose to risk organs in patients receiving Lu-177-Octreotate therapy

Sandström, Mattias; Ilan, Ezgi; Fröss-Baron, Katarzyna; Garske, Ulrike et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

Sundin, Anders; Arnold, Rudolf; Baudin, Eric; Cwikla, Jaroslaw B et al.

Part of Neuroendocrinology, p. 212-244, 2017

• DOI for ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

Knigge, U.; Capdevila, J.; Bartsch, D. K.; Baudin, E. et al.

Part of Neuroendocrinology, p. 310-319, 2017

• DOI for ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

SPECT/CT's Advantage for Preoperative Localization of Small Parathyroid Adenomas in Primary Hyperparathyroidism

Sandqvist, Patricia; Nilsson, Inga-Lena; Grybäck, Per; Sanchez-Crespo, Alejandro et al.

Part of Clinical Nuclear Medicine, p. 109-114, 2017

• DOI for SPECT/CT's Advantage for Preoperative Localization of Small Parathyroid Adenomas in Primary Hyperparathyroidism

18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.

Sundin, Anders; Uhlén, Natalja; Axelsson, Rimma

Part of Clinical Nuclear Medicine, p. 81-82, 2017

• DOI for 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.

Optimisation of penalized likelihood estimation reconstruction (Q.Clear) on a digital time-of-flight PET-CT scanner for four different PET tracers

Lindström, Elin; Lindsjö, Lars; Ilan, Ezgi; Sundin, Anders et al.

Part of Journal of Nuclear Medicine, 2017

Is there a gender difference of absorbed dose to the risk organs in patients receiving ¹⁷⁷Lu-Octreotate therapy?

Sandström, Mattias; Ilan, Ezgi; Sundin, Anders; Lubberink, Mark

Part of Journal of Nuclear Medicine, 2017

Image quality measurements with ¹⁷⁷Lu on a GE Discovery 670 CZT

Sandström, Mattias; Ilan, Ezgi; Sundin, Anders; Lubberink, Mark

Part of Journal of Nuclear Medicine, 2017

Nationellt vårdprogram för adrenala incidentalom - Programmet har harmoniserats med europeiska riktlinjer – ger förenklad handläggning av patienter.

Muth, Andreas; Hammarstedt, Lilian; Hellström, Mikael; Nyman, Ulf et al.

Part of Läkartidningen, 2017

Predictive value of [(18)F]-fluoride PET for monitoring bone remodeling in patients with orthopedic conditions treated with a Taylor spatial frame

Sanchez-Crespo, Alejandro; Christiansson, Frederik; Thur, Charlotte Karlsson; Lundblad, Henrik et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 441-448, 2017

• DOI for Predictive value of [(18)F]-fluoride PET for monitoring bone remodeling in patients with orthopedic conditions treated with a Taylor spatial frame

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management

Öberg, Kjell; Krenning, Eric; Sundin, Anders; Bodei, Lisa et al.

Part of Endocrine Connections, p. 174-187, 2016

• DOI for A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
• Download full text (pdf) of A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

Loskog, Angelica; Maleka, Aglaia; Mangsbo, Sara; Svensson, Emma et al.

Part of British Journal of Cancer, p. 872-880, 2016

• DOI for Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

Assessment of Whether Patients' Knowledge, Satisfaction, and Experience Regarding Their 18F-Fluoride PET/CT Examination Affects Image Quality

Andersson, Camilla; Johansson, Birgitta; Wassberg, Cecilia; Johansson, Silvia et al.

Part of Journal of Nuclear Medicine Technology, p. 21-25, 2016

• DOI for Assessment of Whether Patients' Knowledge, Satisfaction, and Experience Regarding Their 18F-Fluoride PET/CT Examination Affects Image Quality

18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas

Uhlen, Natalja; Grundberg, Oscar; Jacobsson, Hans; Sundin, Anders et al.

Part of Clinical Nuclear Medicine, p. 263-267, 2016

• DOI for 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas

Comparison of PET/CT and PET/MR-based Ga-68-DOTATOC standardized uptake values

Ilan, Ezgi; Sundin, Anders; Velikyan, Irina; Sandström, Mattias et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality

Loizou, L.; Albiin, N.; Leidner, B.; Axelsson, E. et al.

Part of European Radiology, p. 4021-4029, 2016

• DOI for Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

Delle Fave, G.; O'Toole, D.; Sundin, Anders; Taal, B. et al.

Part of Neuroendocrinology, p. 119-124, 2016

• DOI for ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

Ramage, J. K.; De Herder, W. W.; Delle Fave, G.; Ferolla, P. et al.

Part of Neuroendocrinology, p. 139-143, 2016

• DOI for ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

Streptozocin and 5-FU for the treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

Antonodimitrakis, Pantelis; Sundin, Anders; Wassberg, Cecilia; Granberg, Dan et al.

Part of Neuroendocrinology, p. 345-353, 2016

• DOI for Streptozocin and 5-FU for the treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

[¹¹C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy

Schumacher, Martin C; Radecka, Eva; Hellström, Magnus; Jacobsson, Hans et al.

Part of Scandinavian journal of urology, p. 35-42, 2015

• DOI for [¹¹C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy

Recent developments in imaging of pancreatic neuroendocrine tumors

Kartalis, Nikolaos; Mucelli, Raffaella Maria Pozzi; Sundin, Anders

Part of Annals of Gastroenterology, p. 193-202, 2015

Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE

Ilan, Ezgi; Sandström, Mattias; Wassberg, Cecilia; Sundin, Anders et al.

Part of Journal of Nuclear Medicine, p. 177-182, 2015

• DOI for Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE

Static and dynamic CT imaging of the cervical spine in patients with rheumatoid arthritis

Söderman, Tomas; Olerud, Claes; Shalabi, Adel; Alavi, Kamran et al.

Part of Skeletal Radiology, p. 241-248, 2015

• DOI for Static and dynamic CT imaging of the cervical spine in patients with rheumatoid arthritis

Evaluation of a new system for chest tomosynthesis: aspects of image quality of different protocols determined using an anthropomorphic phantom.

Jadidi, M; Sundin, Anders; Aspelin, Peter; Båth, M et al.

Part of British Journal of Radiology, p. 20150057, 2015

• DOI for Evaluation of a new system for chest tomosynthesis: aspects of image quality of different protocols determined using an anthropomorphic phantom.

The Status of Neuroendocrine Tumor Imaging: From Darkness to Light?

Bodei, Lisa; Sundin, Anders; Kidd, Mark; Prasad, Vikas et al.

Part of Neuroendocrinology, p. 1-17, 2015

• DOI for The Status of Neuroendocrine Tumor Imaging: From Darkness to Light?

Fractional contribution of extrapolations after 96 h in absorbed dose calculation to kidneys in 450 patients with neuroendocrine tumours receiving Lu-177-DOTATATE therapy

Sandström, Mattias; Garske-Roman, Ulrike; Granberg, Dan; Sundin, Anders et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2015

Validation of parametric net influx rate images of Ga-68-DOTATOC and Ga-68-DOTATATE

Ilan, Ezgi; Sandström, Mattias; Velikyan, Irina; Sundin, Anders et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2015

Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET

Sangfelt, Per; Sundin, Anders; Wanders, Alkwin; Rasmussen, Ib et al.

Part of Journal of Hepatology, p. 1352-1357, 2014

• DOI for Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET

Can Na18F PET/CT Be Used to Study Bone Remodeling in the Tibia When Patients Are Being Treated with a Taylor Spatial Frame?

Lundblad, Henrik; Maguire, Gerald Q; Olivecrona, Henrik; Jonsson, Cathrine et al.

Part of Scientific World Journal, p. 249326, 2014

• DOI for Can Na18F PET/CT Be Used to Study Bone Remodeling in the Tibia When Patients Are Being Treated with a Taylor Spatial Frame?

Comparison of [68Ga]-DOTA-TOC and [68Ga]-DOTA-TATE: Aspects on quantification in neuroendocrine tumour therapy monitoring

Sundin, Anders; Velikyan, Irina; Sörensen, Jens; Garske-Roman, Ulrike et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Favourable outcome after 177Lu-DOTA-octreotate therapy of patients with neuroendocrine of the rectum -an update

Garske-Roman, Ulrike E.; Sandström, Mattias; Johansson, Silvia; Fröss-Baron, Katarzyna et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas

Eriksson, Olof; Selvaraju, Ram K; Johansson, Lars; Eriksson, Jan W et al.

Part of Journal of Nuclear Medicine, p. 460-465, 2014

• DOI for Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas

The Positron Emission Tomography ligand [11C]5-Hydroxy-Tryptophan can be used as a surrogate marker for the human endocrine pancreas

Eriksson, Olof; Espes, Daniel; Selvaraju, Ram K; Jansson, Emma et al.

Part of Diabetes, p. 3428-3437, 2014

• DOI for The Positron Emission Tomography ligand [11C]5-Hydroxy-Tryptophan can be used as a surrogate marker for the human endocrine pancreas

Technical requirements for Na¹⁸F PET bone imaging of patients being treated using a Taylor spatial frame

Hatherly, Robert; Brolin, Fredrik; Oldner, Åsa; Sundin, Anders et al.

Part of Journal of Nuclear Medicine Technology, p. 33-36, 2014

• DOI for Technical requirements for Na¹⁸F PET bone imaging of patients being treated using a Taylor spatial frame

11C-Hydroxyephedrine Positron Emission Tomography in the Postoperative Management of Pheochromocytoma and Paraganglioma

Yamamoto, Shinji; Wassberg, Cecilia; Hellman, Per; Sundin, Anders

Part of Neuroendocrinology, p. 60-70, 2014

• DOI for 11C-Hydroxyephedrine Positron Emission Tomography in the Postoperative Management of Pheochromocytoma and Paraganglioma

Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification.

Velikyan, Irina; Sundin, Anders; Sörensen, Jens; Lubberink, Mark et al.

Part of Journal of Nuclear Medicine, p. 204-10, 2014

• DOI for Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification.

Streptozocin and 5-fluorouracil treatment of pancreatic neuroendocrine tumors: efficacy, toxicity and prognostic factors

Eriksson, Barbro; Sundin, Anders; Wassberg, Cecilia; Skogseid, Britt et al.

Part of Wiener Klinische Wochenschrift, 2014

11C-acetate-PET/CT for nodal staging in prostatic cancer in correlation with findings at extended pelvic lymphadenectomy and histopathological examination

Sundin, Anders; Schumacher, M.; Radecka, E.; Hellstrom, M. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

⁶⁸Ga-DOTA-TOC-PET/CT detects heart metastases from ileal neuroendocrine tumors

Calissendorff, Jan; Sundin, Anders; Falhammar, Henrik

Part of Endocrine, p. 169-176, 2014

• DOI for ⁶⁸Ga-DOTA-TOC-PET/CT detects heart metastases from ileal neuroendocrine tumors

Computed tomography staging of pancreatic cancer: a validation study addressing interobserver agreement

Loizou, L; Albiin, Nils; Ansorge, C; Andersson, M et al.

Part of Pancreatology, p. 570-575, 2013

• DOI for Computed tomography staging of pancreatic cancer: a validation study addressing interobserver agreement

Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment

Sandström, Mattias; Garske-Román, Ulrike; Granberg, Dan; Johansson, Silvia et al.

Part of Journal of Nuclear Medicine, p. 33-41, 2013

• DOI for Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment

Comparative Biodistribution and Radiation Dosimetry of Ga-68-DOTATOC and Ga-68-DOTATATE in Patients with Neuroendocrine Tumors

Sandström, Mattias; Velikyan, Irina; Garske-Roman, Ulrike; Sörensen, Jens et al.

Part of Journal of Nuclear Medicine, p. 1755-1759, 2013

• DOI for Comparative Biodistribution and Radiation Dosimetry of Ga-68-DOTATOC and Ga-68-DOTATATE in Patients with Neuroendocrine Tumors

Comparison of radiation dosimetry of [Ga-68]Ga-DOTA-TOC and [Ga-68]Ga-DOTA-TATE in patients affected by neuroendocrine tumours

Velikyan, Irina; Sandström, Mattias; Garske, Ulrike; Sörensen, Jens et al.

Part of Journal of labelled compounds & radiopharmaceuticals, 2013

Biological effective doses in 300 patients undergoing therapy with Lu-177-octreotate

Sandström, Mattias; Garske-Roman, Ulrike; Granberg, Dan; Eriksson, B. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013

Low tube voltage CT for improved detection of pancreatic cancer: detection threshold for small, simulated lesions

Holm, Jon; Loizou, Louiza; Albiin, Nils; Kartalis, Nikolaos et al.

Part of BMC Medical Imaging, p. 20, 2012

• DOI for Low tube voltage CT for improved detection of pancreatic cancer: detection threshold for small, simulated lesions

Imaging of adrenal masses with emphasis on adrenocortical tumors

Sundin, Anders

Part of Theranostics, p. 516-522, 2012

• DOI for Imaging of adrenal masses with emphasis on adrenocortical tumors

Lessons on Tumour Response: Imaging during Therapy with Lu-177-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma

Garske, Ulrike; Sandström, Mattias; Johansson, Silvia; Granberg, Dan et al.

Part of Theranostics, p. 459-471, 2012

• DOI for Lessons on Tumour Response: Imaging during Therapy with Lu-177-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma

Preclinical evaluation of a ⁶⁸Ga-labeled biotin analogue for applications in islet transplantation

Eriksson, Olof; Carlsson, Fredrik; Blom, Elisabeth; Sundin, Anders et al.

Part of Nuclear Medicine and Biology, p. 415-421, 2012

• DOI for Preclinical evaluation of a ⁶⁸Ga-labeled biotin analogue for applications in islet transplantation

Combination chemotherapy in advanced adrenocortical carcinoma

Fassnacht, Martin; Terzolo, Massimo; Allolio, Bruno; Baudin, Eric et al.

Part of New England Journal of Medicine, p. 2189-2197, 2012

• DOI for Combination chemotherapy in advanced adrenocortical carcinoma

The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy

Suzuki, C; Blomqvist, L; Sundin, Anders; Jacobsson, H et al.

Part of Annals of Oncology, p. 948-954, 2012

• DOI for The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy

¹¹C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases

Norlén, Olov; Nilsson, Anders; Krause, Johan; Stålberg, Peter et al.

Part of Nuclear Medicine and Biology, p. 883-890, 2012

• DOI for ¹¹C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases

11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma: a single center experience over 11 years

Yamamoto, Shinji; Hellman, Per; Wassberg, Cecilia; Sundin, Anders

Part of Journal of Clinical Endocrinology and Metabolism, p. 2423-2432, 2012

• DOI for 11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma: a single center experience over 11 years

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms

Caplin, Martyn; Sundin, Anders; Nillson, Ola; Baum, Richard P et al.

Part of Neuroendocrinology, p. 88-97, 2012

• DOI for ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms

Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead

Sundin, Anders; Rockall, Andrea

Part of Neuroendocrinology, p. 261-271, 2012

• DOI for Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead

Imaging of neuroendocrine tumors

Sundin, Anders

Part of Expert Opinion in Medical Diagnostics, p. 473-483, 2012

• DOI for Imaging of neuroendocrine tumors

Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours

Sundin, Anders

Part of Baillière's Best Practice & Research, p. 803-818, 2012

• DOI for Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours

MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra

Skorpil, Mikael; Söderlund, Veli; Sundin, Anders; Svenningsson, Per

Part of Journal of Parkinson's Disease, p. 171-180, 2012

• DOI for MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra

PET-Guided Surgery: High Correlation between Positron Emission Tomography with ¹¹C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours

Örlefors, Håkan; Sundin, Anders; Eriksson, Barbro; Skogseid, Britt et al.

Part of Cancers, p. 100-112, 2012

• DOI for PET-Guided Surgery: High Correlation between Positron Emission Tomography with ¹¹C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours

Decreased defluorination using the novel beta-cell imaging agent [¹⁸F]FE-DTBZ-d4 in pigs examined by PET

Jahan, Mahabuba; Eriksson, Olof; Johnström, Peter; Korsgren, Olle et al.

Part of EJNMMI Research, p. 33, 2011

• DOI for Decreased defluorination using the novel beta-cell imaging agent [¹⁸F]FE-DTBZ-d4 in pigs examined by PET

Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography

Eriksson, Olof; Sadeghi, Arian; Carlsson, Björn; Eich, Torsten et al.

Part of Nuclear Medicine and Biology, p. 827-833, 2011

• DOI for Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography

Minor changes in effective half-life during fractionated ¹⁷⁷Lu-Octreotate therapy

Garske, Ulrike; Sandström, Mattias; Johansson, Silvia; Sundin, Anders et al.

Part of Acta Oncologica, p. 86-96, 2011

• DOI for Minor changes in effective half-life during fractionated ¹⁷⁷Lu-Octreotate therapy

Does enteral contrast increase the accuracy of appendicitis diagnosis?

Latifi, Ali; Labruto, Fausto; Kaiser, Sylvie; Ullberg, Ulla et al.

Part of Radiologic Technology, p. 294-299, 2011

Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm

Nilsson, Inga-Lena; Arnberg, Fabian; Zedenius, Jan; Sundin, Anders

Part of World Journal of Surgery, p. 2691-2697, 2011

• DOI for Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm

Diffusion tensor fiber tractography of the olfactory tract

Skorpil, Mikael; Rolheiser, Tyler; Robertson, Harold; Sundin, Anders et al.

Part of Magnetic Resonance Imaging, p. 289-292, 2011

• DOI for Diffusion tensor fiber tractography of the olfactory tract

Metomidate-based imaging of adrenal masses

Hahner, S; Sundin, Anders

Part of Hormones & cancer, p. 348-353, 2011

• DOI for Metomidate-based imaging of adrenal masses

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

Janson, Eva Tiensuu; Sørbye, Halfdan; Welin, Staffan; Federspiel, Birgitte et al.

Part of Acta Oncologica, p. 740-756, 2010

• DOI for Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

In vivo binding of [⁶⁸Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass

Velikyan, Irina; Sundin, Anders; Eriksson, Barbro; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 265-275, 2010

• DOI for In vivo binding of [⁶⁸Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass

In vivo and in vitro characterization of [¹⁸F]-FE-(+)-DTBZ as a tracer for beta-cell mass

Eriksson, Olof; Jahan, Mahabuba; Johnström, Peter; Korsgren, Olle et al.

Part of Nuclear Medicine and Biology, p. 357-363, 2010

• DOI for In vivo and in vitro characterization of [¹⁸F]-FE-(+)-DTBZ as a tracer for beta-cell mass

Individualized dosimetry in patients undergoing therapy with Lu-177-DOTA-D-Phe(1)-Tyr(3)-octreotate

Sandström, Mattias; Garske, Ulrike; Granberg, Dan; Sundin, Anders et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 212-225, 2010

• DOI for Individualized dosimetry in patients undergoing therapy with Lu-177-DOTA-D-Phe(1)-Tyr(3)-octreotate

ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors

Kos-Kudła, Beata; O'Toole, Dermot; Falconi, Massimo; Gross, David et al.

Part of Neuroendocrinology, p. 341-350, 2010

• DOI for ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors

Imaging biomarkers for diagnosis and quantification with positron emission tomography: assistance to therapy

Velikyan, Irina; Sundin, Anders; Eriksson, Barbro; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 724-724, 2010

• DOI for Imaging biomarkers for diagnosis and quantification with positron emission tomography: assistance to therapy

¹¹C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism

Hennings, Joakim; Sundin, Anders; Hägg, Anders; Hellman, Per

Part of Langenbeck's archives of surgery (Print), p. 963-967, 2010

• DOI for ¹¹C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism

Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism

Hennings, Joakim; Andreasson, S.; Botling, Johan; Hägg, Anders et al.

Part of Langenbeck's archives of surgery (Print), p. 133-137, 2010

• DOI for Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism

The value of C-11-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center

Nikolaou, A.; Thomas, D.; Kampanellou, C.; Alexandraki, K. et al.

Part of Journal of Endocrinological Investigation, p. 794-799, 2010

• DOI for The value of C-11-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center

Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria

Suzuki, Chikako; Torkzad, Michael R.; Jacobsson, Hans; Åström, Gunnar et al.

Part of Acta Oncologica, p. 509-514, 2010

• DOI for Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria

Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography

Razifar, Pasha; Hennings, Joakim; Monazzam, Azita; Hellman, Per et al.

Part of BMC Medical Imaging, 2009

• DOI for Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Byström, Per; Berglund, A.; Garske, Ulrike Garske; Jacobsson, H. et al.

Part of Annals of Oncology, p. 1057-1061, 2009

• DOI for Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations

Sundin, Anders; Vullierme, Marie-Pierre; Kaltsas, Gregory; Plöckinger, Ursula et al.

Part of Neuroendocrinology, p. 167-183, 2009

• DOI for ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations

Positron emission tomography in clinical islet transplantation

Eriksson, Olof; Eich, Torsten; Sundin, Anders; Tibell, Annika et al.

Part of American Journal of Transplantation, p. 2816-2824, 2009

• DOI for Positron emission tomography in clinical islet transplantation

Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas

Hennings, Joakim; Hellman, Per; Ahlström, Håkan; Sundin, Anders

Part of European Journal of Radiology, p. 314-23, 2009

• DOI for Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas

The risk of exaggerated risk aversion: a life and death struggle for molecular imaging

Långström, Bengt; Grahnen, Anders; Honoré, Per Hartvig; Borlak, Jürgen et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1693-1694, 2009

• DOI for The risk of exaggerated risk aversion: a life and death struggle for molecular imaging

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with In-111-Pentetreotide

Kwekkeboom, Dik J.; Krenning, Eric P.; Scheidhauer, Klemens; Lewington, Val et al.

Part of Neuroendocrinology, p. 184-189, 2009

• DOI for ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with In-111-Pentetreotide

[Positron emission tomography in neuroendocrine tumours]

Biermann, Martin; Johnsen, Boel; Sørbye, Halfdan; Følling, Magne et al.

Part of Tidsskrift for Den norske lægeforening, p. 1474-1477, 2009

• DOI for [Positron emission tomography in neuroendocrine tumours]

Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors

Wassélius, Johan; Larsson, Stig; Sundin, Anders; Jacobsson, Hans

Part of The international journal of cardiovascular imaging, p. 133-40, 2009

• DOI for Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors

High success rate of parathyroid reoperation may be achieved with improved localization diagnosis

Hessman, Ola; Stålberg, Peter; Sundin, Anders; Garske, Ulrike et al.

Part of World Journal of Surgery, p. 774-81; discussion 782, 2008

• DOI for High success rate of parathyroid reoperation may be achieved with improved localization diagnosis

High 18F-FDG Uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients

Wassélius, Johan; Malmstedt, Jonas; Kalin, Bo; Larsson, Stig et al.

Part of Journal of Nuclear Medicine, p. 1601-5, 2008

• DOI for High 18F-FDG Uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients

Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling

Burman, Pia; Lethagen, ÅsaLinda; Ivancev, Krasnodar; Johansson, Leif et al.

Part of European Journal of Endocrinology, p. 483-8, 2008

• DOI for Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling

Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma

Plöckinger, Ursula; Couvelard, Anne; Falconi, Massimo; Sundin, Anders et al.

Part of Neuroendocrinology, p. 20-30, 2008

• DOI for Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma

Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours

Ekberg, Tomas; Sörensen, Jens; Engström, Mats; Blomquist, Erik et al.

Part of Acta Oto-Laryngologica, p. 186-193, 2007

• DOI for Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Ekeblad, Sara; Sundin, Anders; Janson, Eva Tiensuu; Welin, Staffan et al.

Part of Clinical Cancer Research, p. 2986-2991, 2007

• DOI for Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Kindmark, Henrik; Sundin, Anders; Granberg, Dan; Dunder, Kristina et al.

Part of Medical Oncology, p. 330-337, 2007

• DOI for Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Positron emission tomography: A real-time tool to quantify early islet engraftment in a preclinical large animal model

Eich, Torsten; Eriksson, Olof; Sundin, Anders; Estrada, Sergio et al.

Part of Transplantation, p. 893-898, 2007

• DOI for Positron emission tomography: A real-time tool to quantify early islet engraftment in a preclinical large animal model

Biodistribution of At-211-Labeled humanized monoclonal antibody A33

Almqvist, Ylva; Steffen, Ann-Charlott; Lundqvist, Hans; Jensen, Holger et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 480-487, 2007

• DOI for Biodistribution of At-211-Labeled humanized monoclonal antibody A33

Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis

Cunningham, Janet Lynn; Grimelius, Lars; Sundin, Anders; Agarwal, Smriti et al.

Part of Acta Oncologica, p. 747-756, 2007

• DOI for Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis

Nuclear imaging of neuroendocrine tumours

Sundin, Anders; Garske, Ulrike; Örlefors, Hakan

Part of Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism, p. 69-85, 2007

• DOI for Nuclear imaging of neuroendocrine tumours

In vitro and in vivo characterization of 177Lu‑huA33: A radioimmunoconjugate against colorectal cancer

Almqvist, Ylva; Steffen, Ann-Charlott; Tolmachev, Vladimir; Divgi, Chaitanya R. et al.

Part of Nuclear Medicine and Biology, p. 991-998, 2006

• DOI for In vitro and in vivo characterization of 177Lu‑huA33: A radioimmunoconjugate against colorectal cancer

Gastrinoma (duodenal and pancreatic)

Jensen, Robert T.; Niederle, Bruno; Mitry, Emmanuel; Ramage, John K. et al.

Part of Neuroendocrinology, p. 173-182, 2006

• DOI for Gastrinoma (duodenal and pancreatic)

[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings

Hennings, Joakim; Lindhe, Örjan; Bergström, Mats; Långström, Bengt et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 1410-4, 2006

• DOI for [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings

Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography

Örlefors, Håkan; Sundin, Anders; Lu, L.; Öberg, Kjell et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 60-65, 2006

• DOI for Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography

Developments in PET for the detection of endocrine tumours

Eriksson, Barbro; Örlefors, Håkan; Öberg, Kjell; Sundin, Anders et al.

Part of Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism, p. 311-324, 2005

• DOI for Developments in PET for the detection of endocrine tumours

5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat

Mahteme, Haile; Sundin, Anders; Larsson, Bengt; Khamis, Harry et al.

Part of Anticancer Research, p. 917-922, 2005

Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

Örlefors, Håkan; Sundin, Anders; Garske, Ulrike; Juhlin, Claes et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 3392-3400, 2005

• DOI for Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

In vitro characterization of 211 At-labeled antibody A33: a potential therapeutic agent against metastatic colorectal carcinoma

Almqvist, Ylva; Orlova, Anna; Sjöström, Anna; Jensen, Holger J. et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 514-523, 2005

• DOI for In vitro characterization of 211 At-labeled antibody A33: a potential therapeutic agent against metastatic colorectal carcinoma

[Limit investigation in cancer of unknown primary site]

Berglund, Ake; Nygren, Peter; Hagberg, Hans; Pahlman, Lars et al.

Part of Lakartidningen, p. 2946-8, 2950, 2005

Intraprostatic blood-flow changes during ProstaLund feedback treatment measured by positron emission tomography.

Wagrell, Lennart; Sundin, Anders; Norlén, Bojohan

Part of J Endourol, p. 873-7, 2005

Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery: an autoradiographic study in the rat

Mahteme, Haile; Larsson, B; Sundin, Anders; Khamis, Harry et al.

Part of European Journal of Cancer, p. 142-147, 2004

• DOI for Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery: an autoradiographic study in the rat

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

Welin, Staffan; Janson, Eva Tiensuu; Sundin, Anders; Stridsberg, Mats et al.

Part of European Journal of Endocrinology, p. 107-112, 2004

• DOI for High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

PET in the diagnosis of neuroendocrine tumors

Sundin, Anders; Eriksson, Barbro; Bergström, Mats; Långström, Bengt et al.

Part of Annals of the New York Academy of Sciences, p. 246-257, 2004

• DOI for PET in the diagnosis of neuroendocrine tumors

Effects of intraprostatic and periprostatic injections of mepivacaine epinephrine on intraprostatic blood flow during transurethral microwave thermotherapy: correlation with [15O]H2O-PET.

Schelin, Sonny; Claezon, Anders; Sundin, Anders; Wagrell, Lennart

Part of J Endourol, p. 965-70, 2004

An unusual case of tumor thrombus in the inferior vena cava: A case report

Radecka, Eva; Brekkan, Einar; Juhlin, Claes; Nilsson, L et al.

Part of Acta Radiologica, p. 160-161, 2003

Octreoscan in patients with bronchial carcinoid tumours.

Granberg, Dan; Sundin, Anders; Tiensuu Janson, Eva; Oberg, Kjell et al.

Part of Clin Endocrinol (Oxf), p. 793-9, 2003

Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33: Implications for in vivo dosimetry

Orlova, Anna; Höglund, Johanna; Lubberink, Mark; Lebeda, Ondrej et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 385-96, 2002

• DOI for Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33: Implications for in vivo dosimetry

The role of PET in localization of neuroendocrine and adrenocortical tumors

Eriksson, Barbro; Bergström, Mats; Sundin, Anders; Juhlin, Claes et al.

Part of Annals of the New York Academy of Sciences, p. 159-169, 2002

• DOI for The role of PET in localization of neuroendocrine and adrenocortical tumors

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Fjällskog, M L; Sundin, A; Westlin, J E; Öberg, K et al.

Part of Med Oncol, p. 35-42, 2002

Use of PET in neuroendocrine tumors: In vivo applications and in vitro studies

Eriksson, Barbro; Bergström, Mats; Örlefors, Håkan; Sundin, Anders et al.

Part of The Quarterly journal of nuclear medicine, p. 68-76, 2000

Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET

Höglund, Johanna; Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans et al.

Part of Nuclear Medicine and Biology, p. 837-43, 2000

• DOI for Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET

Positron emission tomography of experimental melanoma with [⁷⁶Br]5-bromo-2-thiouracil

Mårs, Ulla; Tolmachev, Vladimir; Sundin, Anders

Part of Nuclear Medicine and Biology, p. 845-9, 2000

• DOI for Positron emission tomography of experimental melanoma with [⁷⁶Br]5-bromo-2-thiouracil

[¹¹C]Hyaluronan uptake with positron emission tomography in liver disease

Lindqvist, Ulla; Westerberg, G; Bergström, M; Torsteindottir, I et al.

Part of European Journal of Clinical Investigation, p. 600-607, 2000

• DOI for [¹¹C]Hyaluronan uptake with positron emission tomography in liver disease

PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate

Bergström, Mats; Juhlin, Claes; Bonasera, Tomas A; Sundin, Anders et al.

Part of Journal of Nuclear Medicine, p. 275-282, 2000

Demonstration of (11C) 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography.

Sundin, A; Eriksson, B; Bergström, M; Bjurling, P et al.

Part of Nucl. Med. Biol., 2000

PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer11C-metomidate.

Bergstrom, M; Juhlin, C; Bonasera, TA; Sundin, A et al.

Part of J Nucl Med, p. 275, 2000

Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography.

Sundin, A; Eriksson, B; Bergström, M; Bjurling, P et al.

Part of Nucl Med Biol, p. 33-41, 2000

Conjugate chemistry and cellular processing of EGF-dextran

Carlsson, Jörgen; Blomquist, Erik; Gedda, Lars; Liljegren, Åsa et al.

Part of Acta Oncologica, p. 313-321, 1999

PET with [¹¹C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions

Bergström, Mats; Sörensen, Jens; Khan, Tanweera Shaheena; Juhlin, Claes et al.

Part of Clinical Positron Imaging, p. 339, 1999

• DOI for PET with [¹¹C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions

Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography

Nilsson, Dag; Lennernäs, Hans; Fasth, Karl Johan; Sundin, Anders et al.

Part of European Journal of Pharmaceutical Sciences, p. 185-189, 1999

• DOI for Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography

[¹¹¹In-DPTA-D-Phe¹] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma

Edgren, Maliha; Westlin, J E; Kälkner, K M; Sundin, Anders et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 59-64, 1999

• DOI for [¹¹¹In-DPTA-D-Phe¹] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma

Whole-body PET with [¹¹C]-5-hydroxytryptophan for localization of neuroendocrine tumors

Sundin, Anders; Sörensen, Jens; Örlefors, Håkan; Eriksson, Barbro et al.

Part of Clinical Positron Imaging, p. 338, 1999

• DOI for Whole-body PET with [¹¹C]-5-hydroxytryptophan for localization of neuroendocrine tumors

Positron emission tomography and radioimmunotargeting: general aspects

Lundqvist, Hans; Lubberink, Mark; Tolmachev, Vladimir; Lövqvist, Anna et al.

Part of Acta Oncologica, p. 335-341, 1999

Positron emission tomography in neuroendocrine tumours

Eriksson, Barbro; Örlefors, Håkan; Sundin, Anders; Skogseid, Britt et al.

Part of The Italian Journal of Gastroenterology and Hepatology, 1999

Positron emission tomography and radioimmunotargeting: aspects ofquantification and dosimetry

Lubberink, Mark; Lundqvist, Hans; Westlin, Jan-Erik; Tolmachev, Vladimir et al.

Part of Acta Oncologica, p. 343-349, 1999

Whole-Body PET with [11C]-5-Hydroxytryptophan for Localization of Neuroendocrine Tumors.

Sundin, A; Sörrensen, J; Örlefors, H; Eriksson, B et al.

Part of Clin Positron Imaging, p. 338, 1999

Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases

Mahteme, Haile; Lövqvist, A; Graf, Wilhelm; Lundqvist, Hans et al.

Part of Anticancer Research, p. 843-848, 1998

[PET in neuroendocrine tumors].

Eriksson, B; Örlefors, Håkan; Sundin, Anders; Westlin, J E et al.

Part of Nordisk Medicin, p. 308-312, 1998

[Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate]

Juhlin, C; Törnblom, S; Rastad, J; Bergström, Mats et al.

Part of Nordisk Medicin, p. 306-307, 1998

5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat

Mahteme, Haile; Larsson, B S; Sundin, Anders; Graf, Wilhelm

Part of Anticancer Research, p. 943-949, 1998

[Positron emission tomography in oncology--an introduction]

Långström, Bengt; Sundin, Anders; Bergström, Mats

Part of Nordisk Medicin, p. 299-300, 1998

Efficacy of the hepatocyte-specific contrast medium FP 736-04 for CT in two models of experimental diffuse liver disease

Bergman, Antonina; Magnusson, Anders; Moore, Kevin; Sundin, Anders

Part of Academic Radiology, 1998

• DOI for Efficacy of the hepatocyte-specific contrast medium FP 736-04 for CT in two models of experimental diffuse liver disease

Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum

Nettelbladt, Otto S; Sundin, Anders; Valind, Sven O; Gustafsson, Gunnar R et al.

Part of Journal of Nuclear Medicine, p. 640-647, 1998

Identification of human brain loci processing esophageal sensation using positron emission tomography

Aziz, Q; Andersson, J L; Valind, S; Sundin, Anders et al.

Part of Gastroenterology, p. 50-59, 1997

• DOI for Identification of human brain loci processing esophageal sensation using positron emission tomography

Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder

Stenberg, Å M; Sundin, Anders; Larsson, B S; Läckgren, Göran et al.

Part of Journal of Urology, p. 1937-1941, 1997

• DOI for Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder

Synthesis of l-2,4-Diamino[4-¹¹C]butyric acid and its use in some In vitro and In vivo tumour models

Antoni, Gunnar; Omura, H; Bergström, Mats; Furuya, Y et al.

Part of Nuclear Medicine and Biology, p. 595-601, 1997

• DOI for Synthesis of l-2,4-Diamino[4-¹¹C]butyric acid and its use in some In vitro and In vivo tumour models

Labelling and in vivo evaluation of closo-dodecaborate as a linker for attachment of iodine to radiopharma-ceuticals

Tolmachev, Vladimir; Lundqvist, Hans; Carlsson, Jörgen; Sivaev, Igor et al.

Part of Journal of labelled compounds & radiopharmaceuticals, p. 125-127, 1997

• DOI for Labelling and in vivo evaluation of closo-dodecaborate as a linker for attachment of iodine to radiopharma-ceuticals

PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism

Sundin, Anders; Johansson, C; Hellman, P; Bergström, Mats et al.

Part of Journal of Nuclear Medicine, p. 1766-1170, 1996

In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine

Bergström, Mats; Eriksson, Barbro; Öberg, Kjell; Sundin, Anders et al.

Part of Journal of Nuclear Medicine, p. 32-37, 1996

Analysis of l-[methyl-¹¹C]methionine and metabolites in human plasma by an automated solid-phase extraction and a high-performance liquid chromatographic procedure

Lindner, Karl-Johan; Hartvig, Per; Åkesson, Christina; Tyrefors, Niklas et al.

Part of Journal of Chromatography B, p. 13-19, 1996

• DOI for Analysis of l-[methyl-¹¹C]methionine and metabolites in human plasma by an automated solid-phase extraction and a high-performance liquid chromatographic procedure

PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.

Sundin, Anders; Johansson, C; Hellman, Per; Bergstrom, M et al.

Part of J Nucl Med, p. 1766, 1996

Labelling of polysaccharides using [11C]cyanogen bromide: In vivo and in vitro evaluation of 11C-hyaluronan uptake kinetics

Westerberg, Göran; Bergström, Mats; Gustafson, Stefan; Lindqvist, Ulla et al.

Part of Nuclear Medicine and Biology, p. 251-256, 1995

• DOI for Labelling of polysaccharides using [11C]cyanogen bromide: In vivo and in vitro evaluation of 11C-hyaluronan uptake kinetics

A method for coregistration of PET and MR brain images

Andersson, Jesper L; Sundin, Anders; Valind, Sven

Part of Journal of Nuclear Medicine, p. 1307-1315, 1995

Radioimmunolocalization and quantification of liver metastases and subcutaneous tumours from a human colonic cancer xenografted in the nude rat

Sundin, Anders

Part of Acta Radiologica, Supplement, p. 1-29, 1993

Assessment of congestive heart failure in chest radiographs: Observer performance with two common film-screen systems

Henriksson, Lars; Sundin, Anders; Smedby, Örjan; Albrektsson, Per

Part of Acta Radiologica, p. 469-471, 1990

• DOI for Assessment of congestive heart failure in chest radiographs: Observer performance with two common film-screen systems

Comparison of ⁶⁸Ga-DOTATATE and ¹⁷⁷Lu-DOTATATE kinetics in neuroendocrine tumors

Ilan, Ezgi; Velikyan, Irina; Sandström, Mattias; Andersson, Camilla et al.

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)

Deroose, Christophe M.; Leupe, Hannes; Hicks, Rodney J.; Virgolini, Irene et al.

Part of The Lancet Oncology, 2026

• DOI for Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

Ambrosini, Valentina; Kunikowska, Jolanta; Baudin, Eric; Bodei, Lisa et al.

Part of European Journal of Cancer, p. 56-73, 2021

• DOI for Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

Adrenal myelolipomas

Calissendorff, Jan; Juhlin, Carl Christofer; Sundin, Anders; Bancos, Irina et al.

Part of The Lancet Diabetes and Endocrinology, p. 767-776, 2021

• DOI for Adrenal myelolipomas

Ileal neuroendocrine tumors and heart: not only valvular consequences

Calissendorff, Jan; Maret, Eva; Sundin, Anders; Falhammar, Henrik

Part of Endocrine, p. 743-755, 2015

• DOI for Ileal neuroendocrine tumors and heart: not only valvular consequences

Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges

Castano, J. P.; Sundin, Anders; Maecke, H. R.; Villabona, C. et al.

Part of Cancer Metastasis Review, p. 353-359, 2014

• DOI for Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges

Neuroendocrine tumours: the role of imaging for diagnosis and therapy

van Essen, Martijn; Sundin, Anders; Krenning, Eric P; Kwekkeboom, Dik J

Part of Nature Reviews Endocrinology, p. 102-114, 2014

• DOI for Neuroendocrine tumours: the role of imaging for diagnosis and therapy

Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Janson, Eva Tiensuu; Sorbye, Halfdan; Welin, Staffan; Federspiel, Birgitte et al.

Part of Acta Oncologica, p. 1284-1297, 2014

• DOI for Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Gastroenteropancreatic neuroendocrine tumours

Modlin, Irvin M.; Öberg, Kjell; Chung, Daniel C.; Jensen, Robert T. et al.

Part of The Lancet Oncology, p. 61-72, 2008

• DOI for Gastroenteropancreatic neuroendocrine tumours

Imaging of Neuroendocrine Tumors

Öberg, Kjell; Sundin, Anders

Part of Imaging in Endocrine Disorders, p. 142-151, Karger, 2016

• DOI for Imaging of Neuroendocrine Tumors

Adrenal Molecular Imaging

Sundin, Anders

Part of Imaging in Endocrine Disorders, p. 70-79, Karger, 2016

• DOI for Adrenal Molecular Imaging

Imaging of Neuroendocrine Tumors

Öberg, Kjell; Sundin, Anders

Part of Imaging in Endocrine Disorders, p. 142-151, S. Karger, 2016

Radiological Imaging: Computed Tomography, Magnetic Resonance Imaging and Ultrasonography.

Sundin, Anders; Wills, Mark; Rockall, Andrea

Part of Neuroendocrine Tumors, p. 58-72, Krager, 2015

• DOI for Radiological Imaging: Computed Tomography, Magnetic Resonance Imaging and Ultrasonography.

PET for clinical diagnosis and research in neuroendocrine tumors

Eriksson, Barbro; Bergström, M; Örlefors, Håkan; Sundin, Anders et al.

Part of Diagn Nuclear Medicine 4th edition, p. 747-754, 2003

Safety of intratumoral immunostimulatory LOAd703 gene therapy in patients with advanced cancer

Irenaeus, Sandra; Wenthe, Jessica; Eriksson, Emma; Schiza, Aglaia et al.

Quality of life 30 years after ACL reconstruction-a case series of 73 patients

Söderman, Thomas; Kindlund, Ida; Werner, Suzanne; Mikkelsen, Christina et al.

Immunological evaluation of immunostimulatory gene therapy targeting CD40/4-1BB in advanced cancer patients (LOKON002)

Wenthe, Jessica; Eriksson, Emma; Naseri, Sedigheh; Sandin, Linda et al.

Radiation dosimetry of para-chloro-2-[¹⁸F]fluoroethyl-etomidate:a PET tracer for adrenocortical imaging

Silins, Isabella; Moreno, Adrian; Wall, Anders; Aigbirhio, Franklin et al.

Penalized-likelihood reconstruction of [¹¹C]metomidate PET in patients with primary aldosteronism

Silins, Isabella; Lindström, Elin; Hellman, Per; Antoni, Gunnar et al.

Tumor Growth Rate in Pancreatic Neuroendocrine Tumor patients undergoing systemic therapies

Pettersson, Olof; Bernardo, Yvette; Crona, Joakim; Sundin, Anders